Latest Series A Funding Rounds
Companies raising their first major institutional growth round, from the product they sell to the investors backing their next stage.
- Rounds
- 878 All time
- Disclosed funding
- $34.1B 792 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| D DunaCompany profile Provides a digital passport for every business to automate onboarding and compliance Provides a digital passport for every business to automate onboarding and compliance | €30M | Series A | Fintech | Netherlands | Investors | |
| A AccrualCompany profile AI software for accounting firms, connecting preparation, review and evidence across client engagements. AI software for accounting firms, connecting preparation, review and evidence across client engagements. | $75M | Series A | Fintech | United States | Investors | |
| AL Apeiron LabsCompany profile Apeiron Labs supplies ocean observations through networks of autonomous underwater vehicles and a data platform. Apeiron Labs supplies ocean observations through networks of autonomous underwater vehicles and a data platform. | $9.5M | Series A | Climate tech | United States | Investors | |
| SI Synthpop, Inc.Company profile Builds agentic AI to automate administrative workflows in healthcare operations for payers providers and patients Builds agentic AI to automate administrative workflows in healthcare operations for payers providers and patients | $15M | Series A | Healthtech | United States | Investors | |
| CC Chamber CardioCompany profile Enables cardiologists and health plans to manage heart disease patients under value-based care models Enables cardiologists and health plans to manage heart disease patients under value-based care models | $60M | Series A | Healthtech | United States | Investors | |
| RA Provides AI for running and operating software in production | $125M | Series A | AI | United States | Investors | |
| TA Third Arc BioCompany profile Develops novel multifunctional antibodies for oncology and immunology & inflammation indications Develops novel multifunctional antibodies for oncology and immunology & inflammation indications | $52M | Series A+Series A | Biotech | United States | Investors | |
| G Automates Medicaid renewals and redeterminations using AI data | $7.5M | Series A | Healthtech | United States | Investors | |
| AI Ares InteractiveCompany profile Ares Interactive develops and publishes free-to-play games, combining game production, publishing and ongoing live operations. Ares Interactive develops and publishes free-to-play games, combining game production, publishing and ongoing live operations. | $70M | Series A | Media & gaming | United States | Investors | |
| M MyCCompany profile Centralises employee health data and regulatory compliance for multi-site international organisations Centralises employee health data and regulatory compliance for multi-site international organisations | €10M | Series A | Healthtech | France | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Y Combinator (YC)
Clueso, Santé, Flai
52rounds0led - 2Andreessen Horowitz (a16z)
Eka Robotics, TypeSafe AI, Sharp Performance
29rounds9led - 3General Catalyst
Baba, Melius, Disha (formerly Curelink)
24rounds1led - 4Lightspeed
Warp Sciences, Zenzap, Avarra
21rounds4led - 5Alumni Ventures
Chariot Claims, RegCell, Inc., Lightfield
21rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.